BPC-157
An Emerging Candidate in Spinal Cord Injury Research
A synthetic 15-amino acid peptide showing regenerative and neurovascular potential in preclinical models.
Scientific Background
BPC-157 (Body Protection Compound-157) was originally characterized by research teams in Croatia. Although derived from a protective protein found in human gastric juice, it has demonstrated biological effects extending far beyond the gastrointestinal system in rodent models.
Observed Effects in Preclinical SCI Models
Functional Recovery
Support for improved motor outcomes following traumatic spinal injury.
Secondary Injury Reduction
Modulation of inflammation, oxidative stress, and vascular instability.
Angiogenesis
Improved microcirculation and tissue oxygenation through vascular support.
Neuroprotection
Support for improved motor outcomes following traumatic spinal injury.
Axonal Repair Environment
Encouragement of a biologically supportive repair microenvironment.
Why BPC-157 Remains Underdeveloped
- Limited independent multi-center replication studies
- Reduced commercial incentive due to weak patent positioning
- Not approved by major regulatory agencies (FDA, EMA)
- Mechanistic pathways remain incompletely defined
Opportunities for Future Investigation
- Mechanistic pathway clarification
- Pharmacokinetic and pharmacodynamic profiling
- Independent validation of preclinical findings
- Mechanistic pathway clarification
- Pharmacokinetic and pharmacodynamic profiling
- Independent validation of preclinical findings